Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 5
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Articles

Do Turkish adults really have lower serum levels of high-density lipoprotein cholesterol?

Sadik DuranDuzce University, School of Medicine, Departments of 1Cardiology and 2Clinical Biochemistry, Duzce, Turkey.
,
Ramazan MemisogullariDuzce University, School of Medicine, Departments of 1Cardiology and 2Clinical Biochemistry, Duzce, Turkey.Correspondence[email protected]
,
Abdurrahman CoskunDuzce University, School of Medicine, Departments of 1Cardiology and 2Clinical Biochemistry, Duzce, Turkey.
,
Ozlem YavuzDuzce University, School of Medicine, Departments of 1Cardiology and 2Clinical Biochemistry, Duzce, Turkey.
&
Hatice YukselDuzce University, School of Medicine, Departments of 1Cardiology and 2Clinical Biochemistry, Duzce, Turkey.
Pages 453-459 | Received 01 Jun 2007, Accepted 16 Jul 2007, Published online: 23 May 2017

References

  • Ballantyne C, Arroll B, Shepherd J. Lipids and CVD man-agement: towards a global consensus. Eur Heart J2005; 26: 2224–31.
  • Roeters van Lennep JE, Westerveld T, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implica-tions of gender. Cardiovasc Res 2000; 53: 538–49.
  • Onat A, Kele§I, çetinkaya A, Ba§ar 6, Yildirim B, Erer B, Ceyhan K, Eryonucu B, Sansoy V, Onat A Kele§I, çetinkaya O. Prevalence of coronary mortality and morbidity in the Turkish adult risk factor study: 10 year follow-up suggests coronary ‘epidemic’ [in Turkish]. Turk Kardiyol Dern Ail 2001; 29: 8–19.
  • Onat A, Risc factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1–10.
  • Memi§ogullari R, Taysi S, Bakan E, çapoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003; 21: 291–6.
  • Mahley RW, Palaoglu EK, Atak Z, Dawson-Pepin J, Lan-gois AM, Cheung V, Onat H, Fulks P, Mahley LL Vakar F. Turkish Heart Study: lipids, lipoproteins, and apolipopro-teins. J Lipid Res 1995; 36: 839–59.
  • Onat A, Senocak MS, Surdum-Avci G, Ornek E. Prevalence of coronary heart disease in Turkish adults. Int J Cardiol 1993; 93: 23–31.
  • Onat A. Lipids, Lipoproteins and apolipoproteins among Turks, and impact on coronary heart disease. Anadolu Kardiyol Derg 2004; 4: 236–45.
  • Porsch-Oezcueruemez M, Bilgin Y, Wally M, Gediz A, Arat A, Karatay E, Akinci A, Sinterhauf K, Koch H, Siegfried I, von Georgi R, Brenner G, Kloer HU. Prevalence of risk factors of coronary heart disease in Turks living in Ger-many: The Giessen Study. Atherosclerosis 1999; 144: 185–98.
  • Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ash-wood ER, Bruns DE, editors. Tietz textbook of clinical chem-istry and molecular diagnosis. 4th ed. St. Louis: Elsevier Saun-ders; 2006. p. 948.
  • Westgard JO, Klee GG. Quality management. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnosis. 4th ed. St. Louis: Elsevier Saunders; 2006. p. 485.
  • Onat A, Yildirim B, Uslu N, Gürbüz N, Kele§I, çetinkaya A, Aksu H, Uysal 0, Sansoy V. Investigations plasma lipoproteins and apolipoproteins in Turkish adults: Overall levels, associations with other risk parameters and HDL’s role as a marker of coronary risk in women [in Turkish]. Dirk Kardiyol Dern Ail 1999; 27: 72–9.
  • Bowden RG, Kingery PM, Long L. Precision of a dry-chem-istry method of lipid screening. Public Health 2006; 120: 572–6.
  • Onat A, Ozhan H, Can G, Hergenç G, Karabulut A, Albayrak S. Family income in shaping cardiometabolic risk profile: a prospective analysis including gender-related dif-ferences [in Turkish]. Dirk Kardiyol Dern Ail 2006; 34:471–78.
  • Stein EA. Lipids, Lipoproteins, and Apolipoproteins. In: Tietz NW, ed. Textbook of Clinical Chemistry. Philadelphia: W.B. Saunders Company; 1986, p. 876-882.
  • Johnson, CL, Rifiind BM, Sempos CT, Carroll MD. Bachorik PS, Briefel RR, Gordon DJ, Burt VL, Brown CD, Lippel K. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. J Am Med Assoc 1993; 269: 3002–8.
  • Hergenc G, Schulte H, Assmann G, A. von Eckardstein. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German indi-viduals. Atherosclerosis 1999; 145: 147–56.
  • Ashavaid TF, Kondkar AA, Todur SP, Dhrai AJ, Morey J, Raghavan R. Lipid, lipoprotein, apolipoprotein and lipopro-tein (a) levels: reference intervals in a healthy Indian popu-lation. J Atheroscler Thromb 2005; 12: 251–9.
  • Barcin C, Tapan S, Kursaklioglu H, Iyisoy A, Olcay A, Erbil MK, Isik E. Effects of non-heavy smoking on high-density lipoprotein cholesterol in healthy Turkish young men. Acta Cardiol 2006; 61: 411–5.
  • Mahley RW, Can S, Ozbayrakci S, Bersot TP, Tanir S, Palaoglu KE, Pepin GM. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cardiol 2005; 96: 547–55.
  • Onat A, Ozhan H, Esen AM, Albayrak S, Karabulut A, Can G, Hergenç G. Prospective epidemiologic evidence of a “pro-tective” effect of smoking on metabolic syndrome and dia-betes among Turkish women-Without associated overall health benefit. Atherosclerosis 2007; 193: 380–8.
  • Tavintharan S, Lim SC, Sum CF. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat? Singapore Med J2005; 46: 519-28.
  • Williams CM. Lipid metabolism in women. Proc Nutr Soc 2004; 63: 153–60.
  • Kesteloot H, Sasaki S. On the relationship between nutrition, sex hormones and high density lipoproteins in women. Acta Cardiol 1993; 48: 353–63.
  • Azizi F, Ainy E. Coronary heart disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study. Climacteric 2003; 6: 330–6.
  • Bersot TP, Vega GL, Grundy SM, Palaoglu KE, Atagun-duz P, Ozbayrakci S, Gokdemir 0, Mahley RW. Elevated hepatic lipase activity and low levels of high density lipopro-tein in normotryglyceridemic, nonobese Turkish population. J Lipid Res 1999; 40: 432–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.